Influence of co-medication on the metabolism of valproate
- 1 June 1992
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 14 (3) , 108-113
- https://doi.org/10.1007/bf01962698
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- β‐Oxidation of ValproateEpilepsia, 1989
- Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk FactorsEpilepsia, 1988
- The Toxicity of Metabolites of Sodium Valproate in Cultured HepatocytesThe Journal of Clinical Pharmacology, 1983
- Valproate–Induced Hepatic Steatogenesis in RatsHepatology, 1982
- Sodium Valproate in the Induction of Unusual HepatotoxicityHepatology, 1982
- The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in childrenThe Journal of Pediatrics, 1982
- Serum Concentrations and Enzyme Induction in Epileptic Children Treated with Phenytoin and ValproateNeuropediatrics, 1982
- Concentration of Metabolites of Valproic Acid in Plasma of Epileptic PatientsEpilepsia, 1981
- Clinical Pharmacokinetics of Valproic Acid1Clinical Pharmacokinetics, 1980
- Sodium Valproate in the Treatment of Intractable Childhood EpilepsyDevelopmental Medicine and Child Neurology, 1975